Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System Database: A Disproportionality Analysis

By Shamloo Behrooz K.  

Drug Safety, Vol. 35, Iss. 6, 2012-06 ,pp. : 507-518

Adis International

Access to resources Recommend Favorite

An Experimental Investigation of Masking in the US FDA Adverse Event Reporting System Database

By Wang Hsin-wei  

Drug Safety, Vol. 33, Iss. 12, 2010-12 ,pp. : 1117-1133

Adis International

Access to resources Recommend Favorite

`Extreme Duplication' in the US FDA Adverse Events Reporting System Database

By Hauben Manfred   Reich Lester   DeMicco James   Kim Katherine  

Drug Safety, Vol. 30, Iss. 6, 2007-01 ,pp. : 551-554

Adis International

Access to resources Recommend Favorite

Fluoroquinolone-Associated Myasthenia Gravis Exacerbation: Evaluation of Postmarketing Reports from the US FDA Adverse Event Reporting System and a Literature Review

By Jones S. Christopher   Sorbello Alfred   Boucher Robert M.  

Drug Safety, Vol. 34, Iss. 10, 2011-10 ,pp. : 839-847

Adis International

Access to resources Recommend Favorite

A review of the Vaccine Adverse Event Reporting System database

By Geier David A   Geier Mark R  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 691-698

Informa Healthcare

Access to resources Recommend Favorite